An Thi Pham, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pham’s office at (408) 274-1339 to ask if they take your plan before you enroll.
California Medical Board record
Licence A37379 · Delinquent
Licence status: Delinquent · since 1981 · expires 2023-08-31 · University of Saigon Faculty of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$0 in 2020
Medicaid paid $0 for 14 billed services this clinician did in 2020, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 14 | $0 |
| 2020 | 14 | 1 | 14 | $0 |
| 2019 | 2,178 | 13 | 177 | $15,937 |
| 2018 | 2,979 | 17 | 176 | $30,149 |
See the largest Medicaid services in earlier years
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 164 | $5,523 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 103 | $5,078 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 60 | $2,359 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 77 | $787 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 33 | $489 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 58 | $456 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 12 | $344 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 39 | $337 |
| Skin test; tuberculosis, intradermal | 76 | $222 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 20 | $159 |
| Return visit (30+ min) | 146 | $139 |
| Short return visit | 175 | $43 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 131 | $7,314 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 153 | $6,961 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 179 | $6,595 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 350 | $3,005 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 63 | $1,874 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 106 | $923 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use | 54 | $786 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 83 | $764 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 13 | $609 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 57 | $525 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 12 | $281 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 28 | $208 |
Money from drug and device companies
$121 in 2023
| 2023 | 1 | 1 | None | $121 |
| 2019 | 1 | 1 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Saphnelo | $121 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Meals · 2023-07-10 | Saphnelo | $121 |
See earlier years (2019)
2019: $143
| Amarin Pharma | Vascepa | $143 | 1 payment
|
Professional record
- NPI
- 1578597241
- Licence
- CA A37379California A37379: Delinquent · expires 2023-08-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 1693 Flanigan Dr, Suite # 101, San Jose, CA, 95121
- NPI first listed
- 2006-07-10
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.